EagleClaw Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
EagleClaw Capital Management's LLY Position: Q3 2026 in Review
EagleClaw Capital Management increased its Eli Lilly (LLY) stake by 3.7% in Q3 2026, buying an estimated $76.7K and bringing the position to 1,837 shares worth $2.13M. The position accounts for 0.28% of the portfolio, ranked #73.
EagleClaw Capital Management first reported a position in LLY in Q4 2021 and has held it in 20 quarters since. 3,244 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- EagleClaw Capital Management held 1,837 shares of Eli Lilly worth $2.13M as of Q3 2026.
- EagleClaw Capital Management bought 65 Eli Lilly shares in Q3 2026, an estimated $76.7K.
- Eli Lilly made up 0.28% of EagleClaw Capital Management's portfolio in Q3 2026, its #73 holding.
- EagleClaw Capital Management first reported a position in Eli Lilly in Q4 2021 and has held it in 20 quarters since.
- 3,244 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on EagleClaw Capital Management's 13F filing for Q3 2026, filed 6 Nov 2026.